How do you keep cost of goods (COGs) for viral vector-based medicines within reason to…
Aaron Ogdahl8 November 2022
Adenovirus (Ad) vectors are used to develop gene therapy products and vaccines. Decades of research…
Aaron Ogdahl11 April 2022
Adenoviruses have been explored for gene therapy purposes for many decades. They are DNA viruses,…
Aaron Ogdahl24 March 2022
Written by expert: Kai, Technical Lead The obstacles of viral vector production Over the last…
Aaron Ogdahl28 February 2022
You’ve developed a candidate viral vaccine or viral vector product, and initial preclinical data are…
tristan19 April 2021
Written by expert: Yang, Bioprocess Scientist In 2017, the New York Times wrote an article…
Claire Otjes27 January 2020
Written by expert: Ahd, Director Project Management Current costs of biopharmaceutical manufacturing often prevent segments…
Claire Otjes8 July 2019
Written by expert: Evert, Associate Director DSP With the first gene therapies now being on…
Claire Otjes18 December 2018
Written by expert: Gert, Associate Director Assays HPLC assays have been widely used to analyze…
Claire Otjes4 August 2017
